trial
-
Recon
Pluristem Advances Towards Multinational Phase III Trial of PLX-PAD to Improve Recovery Following Surgery for Hip Fracture
HAIFA, Israel, July 27, 2016 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy…
Read More » -
Hospitals
IlluminOss Medical Completes Enrollment for U.S. Clinical Trial Using Groundbreaking Photodynamic Bone Stabilization System
East Providence, RI (July 18, 2016) – IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive…
Read More » -
Sports Medicine
Presentation of Twelve Month Pilot Trial Data of Cytori® Cell Therapy™ for ACL Reconstruction
SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today Dr. Ramón Cugat MD, Ph.D. will present 12-month follow-up results from…
Read More » -
Hospitals
First meniscus replacement in Safety Using NUsurface clinical trial has been performed
May 20, 2016 SALT LAKE CITY–(BUSINESS WIRE)–Salt Lake Regional Medical Center, an IASIS Healthcare hospital, and Active Implants, a company…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of Second Multicenter Randomized Controlled Trial of the iFuse Implant System vs. Conservative Care in European Spine Journal
SAN JOSE, Calif., May 17, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant…
Read More » -
Spine
Transparency in research: SI-BONE to make clinical trial data accessible via Yale YODA Project
With the ultimate goal of fostering transparency and improving the health of patients, the Yale University Open Data Access (YODA) Project has…
Read More » -
Hospitals
Accused Infringer Turns PTAB Lemons to Trial Court Lemonade
By Peter Leung May 9 — A defendant in a medical device patent trial used the Patent Trial and…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of Two-Year Results From a Prospective Multicenter Clinical Trial Showing Long-Term Clinical Benefits from SI Joint Fusion with the iFuse Implant System
SAN JOSE, Calif., April 20, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More » -
Biologics
Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…
Read More » -
Financial
Amputee receives $1.7M over botched surgery
By Brad Zinn STAUNTON – A jury on Tuesday awarded a woman $1.75 million in a lawsuit where she sued…
Read More » -
Financial
Wright Medical slapped with $11M verdict in bellwether case over metal hip implant
By Emily Wasserman Wright Medical ($WMGI) was dealt a stinging blow in its courtroom battle over its metal hip implant…
Read More » -
Recon
Ember Therapeutics Announce Initial Positive Results From a Phase 2 Trial of BMP-7 in Patients with Moderate Osteoarthritis of the Knee
NEW YORK, Oct. 19, 2015 /PRNewswire/ — Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis,…
Read More » -
Hospitals
Five-Year Clinical Results Confirm Two-Level Mobi-C Superiority to Fusion
AUSTIN, Texas, Oct. 13, 2015 (GLOBE NEWSWIRE) — LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing…
Read More »